68166 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Abbott Laboratories market cap

Abbott Laboratories volume of trade today and historical data of Abbott Laboratories capitalization since start date of trade of ABT stocks.
Add to widgets
Added to widgets

Abbott Laboratories capitalization

Today's market capitalization for Abbott Laboratories is 128 556 048 384 US dollar.
+544 522 240 $ (+0.43%)
change of capitalization since yesterday

Abbott Laboratories volume of trade

Today's Abbott Laboratories volume of trade is 2 048 432 US dollar.
-8 761 103 $ (-81.05%)
change of volume of trade since yesterday
Show:
to

Abbott Laboratories market cap chart

Week Month 3 months Year 3 years

Abbott Laboratories capitalization history

Date Capitalization
Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
18/04/2019 128 556 048 384 $
17/04/2019 128 011 526 144 $
16/04/2019 134 159 171 584 $
15/04/2019 136 723 619 840 $
12/04/2019 136 741 191 680 $
11/04/2019 138 576 691 200 $
10/04/2019 138 708 434 944 $

Abbott Laboratories volume chart

Week Month 3 months Year 3 years

Abbott Laboratories volume history data

Date Volume (24h)
Volume of trade of Abbott Laboratories - total sum in US dollars for all deals with ABT stocks bought and sold during selected date.
18/04/2019 2 048 432 $
17/04/2019 10 809 535 $
16/04/2019 5 610 142 $
15/04/2019 2 189 325 $
12/04/2019 4 420 132 $
11/04/2019 968 485 $
10/04/2019 5 186 524 $

Abbott Laboratories capitalization is 128 556 048 384 $ now. Market capitalization of Abbott Laboratories changed by +0.43% since yesterday. Today's volume of trade of ABT stocks was 2 048 432 $. ABT volume of trade amount changed to -81.0498% since yesterday.

Abbott Laboratories stocks data

Abbott Laboratories financials